The official abstract submission period for the 2027 conference is now open, and we'd be honored to help you showcase your drug discovery, lab automation and screening research to the greater European life sciences community.
The SLAS Europe 2027 Conference and Exhibition will unite the European life sciences and laboratory technology community in Hamburg, Germany, 25-27 May 2027.
What to Expect at SLAS Europe 2027 Conference and Exhibition
behind-the-scenes Technology Provider Showcase;
pre-conference short courses;
valuable access to revolutionary lab automation and biotech innovation through scientific sessions and insightful presentations;
Founder, CEO and CBO Insilico Medicine (United States)
Alex Zhavoronkov, PhD, is the founder, CEO and CBO of Insilico Medicine, a leading clinical-stage biotechnology company developing next-generation generative artificial intelligence and automation platforms for drug discovery. Since 2012, he has published over 310 peer-reviewed research papers with over 30 papers in the field of generative adversarial networks, generative reinforcement learning, and multi-modal transformers, and 3 books, including "The Ageless Generation: How Biomedical Advances Will Transform the Global Economy" (Macmillan, 2013).